… whether the initiation of tiotropium monotherapy affects the risk … with COPD should avoid tiotropium due to concerns about … measures, and other anticholinergic drugs. The assumption that the … The data for midlife medication dispensing and dementia biomarkers …

… trials have demonstrated its benefits, establishing these combinations as a key treatment … of individual medications, pharmaceutical manufacturers, dosages, or various drug combinations. However … -daily indacaterol versus tiotropium for patients with severe …

… with Lupin, a global pharmaceutical leader, on Tiotropium DPI," said Wang … deep commitment to respiratory disease treatment and its innovation-driven approach … significant breakthroughs in respiratory disease treatment in China, allowing more patients …

… Pharmaceuticals (SUP) for commercialisation of chronic obstructive pulmonary disease drug Tiotropium … critical products for the treatment of respiratory diseases such … significant breakthroughs in respiratory disease treatment in China, allowing more …

… Universal Pharmaceuticals. The company is working towards selling Tiotropium Dry … Chinese pharmaceutical company, Shenzhen Foncoo Pharmaceutical, to launch generic medicines. The … Yabao Pharmaceutical, another Chinese firm, to launch pediatric drugs targeting …

… Lupin, a global pharmaceutical leader, on tiotropium DPI," said … significant breakthroughs in respiratory disease treatment in China, allowing more … formulations, complex generics, biotechnology products, and active pharmaceutical ingredients.    Sino …

… with Sino Universal Pharmaceuticals for the commercialization of Tiotropium Dry Powder Inhaler … inhaler is used in the treatment of chronic obstructive pulmonary disease … the world’s fastest-growing pharmaceutical markets. Fabrice Egros, President of …

… Sino Universal Pharmaceuticals (SUP), for the commercialisation of Tiotropium Dry Powder … for the treatment of chronic obstructive pulmonary disease (COPD). Tiotropium dry powder … developing critical products for the treatment of respiratory diseases such …

Commenting on the partnership, SUP President Wang Li said, "Lupin's deep commitment to respiratory disease treatment and its innovation-driven approach to high-quality products align perfectly with SUP's strategic vision. We believe this …

… Lupin, a global pharmaceutical leader, on Tiotropium DPI," said … significant breakthroughs in respiratory disease treatment in China, allowing more … , complex generics, biotechnology products, and active pharmaceutical ingredients. The company …